TELIX PHARMACEUTICALS
TLX·87961M105·US·ADR·Healthcare - Biotechnology
TLX (TELIX PHARMACEUTICALS) is held by 22 institutional investors as of Q1 2026. Largest holders: FMR LLC ($5.4M), LAZARD ASSET MANAGEMENT LLC ($2.8M), Private Advisor Group, LLC ($1.7M). Net institutional sentiment: Mixed.
22
Holders
Avg rating(7 Elite)
$15.2M
Total Value
65% (28)
Fund Consensus
17 buying - 9 selling
Who's Trading
InsiderBCBehrenbruch ChristianBuy $497KApr 29, 2026
InsiderBCBehrenbruch ChristianBuy $500KApr 28, 2026
13F: Insider & Congress:
Showing 1-20 of 28
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer